ed as an early and accurate marker using less invasive techniques for the diagnosis, especially in neutropenic patients, with advantages of less injury and time-efficient, though sometimes this test in blood samples are less sensitive than cultures of respiratory samples [25].
The treatment recommendations can be supported by the 2016 Update guideline by the Infectious Diseases Society